Publications by authors named "Joshua Anthony"

Claim this Profile
I
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Takami Sato, Marcus O Butler, Sophie Piperno-Neumann, Jessica C Hassel, Paul Nathan, Anthony M Joshua

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial.
Rui M Bernardino, Leyi B Yin, Katherine Lajkosz, Eric Winquist, Jessica G Cockburn, Anthony M Joshua

Eur Urol Open Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Active Surveillance Trial in Low-Risk Prostate Cancer.
Neil E Fleshner, Rui M Bernardino, Jonathan Izawa, Darrel Drachenberg, Jeff W Saranchuk, Anthony M Joshua

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.
Neil Portman, Blossom Mak, Nicole Yeung, Hui-Ming Lin, Rachel M N Kim, Anthony M Joshua

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Menopause: Ending the Inequality-Why Men with Prostate Cancer Still Lack Therapies for Hot Flushes.
Martino Pedrani, Silke Gillessen, Erik Briers, Pierre Blanchard, Anthony M Joshua

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Nonfinancial Conflicts of Interest in Oncology Research-A Guide for Practice.
Annabelle D Robinson, Anthony M Joshua, Wendy Lipworth

JAMA Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized nutrition: perspectives on challenges, opportunities, and guiding principles for data use and fusion.
Sharon M Donovan, Mariette Abrahams, Joshua C Anthony, Ying Bao, Maribel Barragan

Crit Rev Food Sci Nutr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.
Samantha Shekar, Megan Crumbaker, Anthony Joshua, Andrew Yam, Phillip Stricker

BJUI Compass· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.
Mitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, Ashlee K Clark, Georgia B Cuffe, Anthony M Joshua

Eur Urol Focus· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors.
Jia Liu, Anna R Minchom, Alastair Greystoke, Thomas R J Evans, Debashis Sarker, Anthony M Joshua

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial.
Louise Emmett, Nathan Papa, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M Joshua

Lancet Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review.
Farzana Y Zaman, Aisha Ghaus, Mark Shackleton, Damien Kee, Anthony M Joshua

Clin Exp Ophthalmol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Hot Flash Management in Patients With Prostate Cancer.
Kevin Lawrence Lin, Barak Talmor, Megan Crumbaker, Anthony Michael Joshua

J Clin Endocrinol Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.
Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer, Louise Emmett, Shahneen Sandhu, Anthony M Joshua

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Megan B Barnet, Katherine J L Jackson, Etienne Masle-Farquhar, Amanda Russell, Deborah L Burnett, Anthony M Joshua

Proc Natl Acad Sci U S A· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study.
Colin Williams, Andrisha-Jade Inderjeeth, Wei Hong, Jane McKenzie, Angelyn Anton, Anthony Joshua

Clin Genitourin Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study.
Tim Luckett, Carrie-Anne Ng, Julia Lai-Kwon, Damien Kee, Brendan Mulhern, Anthony M Joshua

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to publishing early phase clinical trials: the oncologists' perspective.
Merel J J Lucassen, Pedro Bergmann, Olga Husson, Udai Banerji, Bristi Basu, Anthony M Joshua

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Ciara Conduit, Andrisha-Jade Inderjeeth, Raymond Allen, Andrew J Martin, Wendy Parulekar, Anthony Joshua

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective: Challenges for Personalized Nutrition in the Current United States Regulatory Framework and Future Opportunities.
Sharon M Donovan, Mariette Abrahams, Joshua C Anthony, Robert Bergia, Gil Blander

Adv Nutr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival and quality of life with [Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial.
Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Anthony M Joshua, Shahneen Sandhu

Lancet Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Cecilia R Chambers, Supitchaya Watakul, Peter Schofield, Anna E Howell, Jessie Zhu, Anthony M Joshua, Anthony J Gill

Sci Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Wafik S El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A Carneiro, Don S Dizon, Anthony M Joshua

Oncotarget· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.
Jia Liu, Max Farrow, Lesley Seymour, Jayesh Desai, Herbert H Loong, Anthony W Tolcher, Anthony M Joshua

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in Men.
Kevin L Lin, Samantha Shekar, Megan Crumbaker, Anthony M Joshua

N Engl J Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis